Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine or Esketamine for Postoperative Behavioral Changes in Children
NCT07570160Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Nanjing Medical University
- Start
- Jun 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in behavioral disorder, sponsored by Children's Hospital of Nanjing Medical University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
behavioral disorder
Beyond the preview
Go deeper on NCT07570160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07570160.